Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Atherosclerosis ; 186(1): 38-53, 2006 May.
Article in English | MEDLINE | ID: mdl-16076471

ABSTRACT

The epidermal growth factor receptor is a member of type-I growth factor receptor family with tyrosine kinase activity that is activated following the binding of multiple cognate ligands. Several members of the EGF family of ligands are expressed by cells involved in atherogenesis. EGF receptor mediated processes have been well characterised within epithelial, smooth muscle and tumour cell lines in vitro, and the EGF receptor has been identified immunocytochemically on intimal smooth muscle cells within atherosclerotic plaques. There is also limited evidence for the expression of the EGF receptor family on leukocytes, although their function has yet to be clarified. In this review, we will discuss the biological functions of this receptor and its ligands and their potential to modulate the function of cells involved in the atherosclerotic process.


Subject(s)
Atherosclerosis/metabolism , ErbB Receptors/metabolism , Atherosclerosis/genetics , ErbB Receptors/genetics , Gene Expression , Humans , Ligands , Monocytes/metabolism , Risk Factors
2.
Atherosclerosis ; 172(1): 13-20, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14709352

ABSTRACT

An immune response to heat shock protein (HSP)-60/65 has recently been implicated in atherogenesis. The aim of this study was to determine whether this effect may be mediated by impairment of endothelial function. Rabbits were injected with bacillus Calmette-Guerin (BCG) vaccine (n=12) or saline (n=12). A further injection of BCG or saline was administered after 2 weeks. After a further 2 weeks, animals were fed either a 0.25-1% cholesterol diet or a chow diet for 16 weeks. Blood cholesterol levels were maintained at 10-12mmol/l by altering the dietary cholesterol content. Plasma levels of anti-mycobacterial antibodies rose following BCG immunisation, but anti-HSP antibodies developed only in the BCG-immunised, cholesterol-fed rabbits. Aortic endothelium from cholesterol-fed, but not chow-fed, rabbits stained positively for HSP-60, independently of the immunisation protocol. Endothelial function was impaired in the BCG immunised, cholesterol-fed rabbits as measured by acetylcholine-mediated relaxation of isolated non-atherosclerotic carotid artery rings (P<0.05). This impairment was positively associated with the level of plasma anti-HSP-60 antibodies (P<0.01). These results suggest that BCG immunisation impairs endothelial responses, at least in part, by immune responses against mycobacterial and vascular HSP.


Subject(s)
BCG Vaccine/immunology , Chaperonin 60/immunology , Endothelium, Vascular/physiology , Hypercholesterolemia/immunology , Animals , Antibodies, Bacterial/blood , Aorta/immunology , Arteriosclerosis/immunology , Cholesterol/blood , Endothelium, Vascular/immunology , Immunization , Immunohistochemistry , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...